187 related articles for article (PubMed ID: 22155602)
21. Associations between cytochrome P4502E1 genotype, mutagen sensitivity, cigarette smoking and susceptibility to lung cancer.
Wu X; Shi H; Jiang H; Kemp B; Hong WK; Delclos GL; Spitz MR
Carcinogenesis; 1997 May; 18(5):967-73. PubMed ID: 9163682
[TBL] [Abstract][Full Text] [Related]
22. CYP2E1PstI/RsaI polymorphism and interaction with tobacco, alcohol and GSTs in gastric cancer susceptibility: A meta-analysis of the literature.
Boccia S; De Lauretis A; Gianfagna F; van Duijn CM; Ricciardi G
Carcinogenesis; 2007 Jan; 28(1):101-6. PubMed ID: 16837478
[TBL] [Abstract][Full Text] [Related]
23. Elucidation of CYP2E1 5' regulatory RsaI/Pstl allelic variants and their role in risk for oral cancer.
Liu S; Park JY; Schantz SP; Stern JC; Lazarus P
Oral Oncol; 2001 Jul; 37(5):437-45. PubMed ID: 11377232
[TBL] [Abstract][Full Text] [Related]
24. Functional PstI/RsaI polymorphism in CYP2E1 is associated with the development, progression and poor outcome of gastric cancer.
Feng J; Pan X; Yu J; Chen Z; Xu H; El-Rifai W; Zhang G; Xu Z
PLoS One; 2012; 7(9):e44478. PubMed ID: 22957075
[TBL] [Abstract][Full Text] [Related]
25. Functional RsaI/PstI polymorphism in cytochrome P450 2E1 contributes to bladder cancer susceptibility: evidence from a meta-analysis.
Deng XD; Gao Q; Zhang B; Zhang LX; Zhang W; Mu Er ZE; Xie Y; Ma Y; Liu Y
Asian Pac J Cancer Prev; 2014; 15(12):4977-82. PubMed ID: 24998574
[TBL] [Abstract][Full Text] [Related]
26. Genetic polymorphisms of CYP2E1 and GSTM1 in a Thai population.
Sangrajrang S; Jedpiyawongse A; Srivatanakul P
Asian Pac J Cancer Prev; 2006; 7(3):415-9. PubMed ID: 17059334
[TBL] [Abstract][Full Text] [Related]
27. Lack of association of cytochrome P450 2E1 genetic polymorphisms with the risk of human hepatocellular carcinoma.
Lee HS; Yoon JH; Kamimura S; Iwata K; Watanabe H; Kim CY
Int J Cancer; 1997 May; 71(5):737-40. PubMed ID: 9180139
[TBL] [Abstract][Full Text] [Related]
28. Relationship between genetic polymorphisms of metabolizing enzymes CYP2E1, GSTM1 and Kazakh's esophageal squamous cell cancer in Xinjiang, China.
Lu XM; Zhang YM; Lin RY; Arzi G; Wang X; Zhang YL; Zhang Y; Wang Y; Wen H
World J Gastroenterol; 2005 Jun; 11(24):3651-4. PubMed ID: 15968714
[TBL] [Abstract][Full Text] [Related]
29. CYP2E1 PstI/RsaI polymorphism and interaction with alcohol consumption in hepatocellular carcinoma susceptibility: evidence from 1,661 cases and 2,317 controls.
Liu C; Wang H; Pan C; Shen J; Liang Y
Tumour Biol; 2012 Aug; 33(4):979-84. PubMed ID: 22249978
[TBL] [Abstract][Full Text] [Related]
30. CYP1A1 and CYP2E1 genotypes and risk of esophageal squamous cell carcinoma in a high-incidence region, Kashmir.
Bhat GA; Shah IA; Makhdoomi MA; Iqbal B; Rafiq R; Nabi S; Masood A; Lone MM; Dar NA
Tumour Biol; 2014 Jun; 35(6):5323-30. PubMed ID: 24504680
[TBL] [Abstract][Full Text] [Related]
31. Genetic polymorphisms of aldehyde dehydrogenase 2, cytochrome p450 2E1 for liver cancer risk in HCV antibody-positive japanese patients and the variations of CYP2E1 mRNA expression levels in the liver due to its polymorphism.
Kato S; Tajiri T; Matsukura N; Matsuda N; Taniai N; Mamada H; Yoshida H; Kiyam T; Naito Z
Scand J Gastroenterol; 2003 Aug; 38(8):886-93. PubMed ID: 12940444
[TBL] [Abstract][Full Text] [Related]
32. CYP2E1 PstI/RsaI polymorphism and colorectal cancer risk: a meta-analysis.
Zhou GW; Hu J; Li Q
World J Gastroenterol; 2010 Jun; 16(23):2949-53. PubMed ID: 20556843
[TBL] [Abstract][Full Text] [Related]
33. CYP2E1 RsaI/PstI polymorphism and liver cancer risk among east Asians: a HuGE review and meta-analysis.
Tian Z; Li YL; Zhao L; Zhang CL
Asian Pac J Cancer Prev; 2012; 13(10):4915-21. PubMed ID: 23244081
[TBL] [Abstract][Full Text] [Related]
34. The RsaI polymorphism of CYP2E1 and susceptibility to alcoholic liver disease in Caucasians: effect on age of presentation and dependence on alcohol dehydrogenase genotype.
Grove J; Brown AS; Daly AK; Bassendine MF; James OF; Day CP
Pharmacogenetics; 1998 Aug; 8(4):335-42. PubMed ID: 9731720
[TBL] [Abstract][Full Text] [Related]
35. Genetic polymorphism of cytochrome P450 2E1 in the Turkish population.
Omer B; Ozbek U; Akköse A; Kiliç G
Cell Biochem Funct; 2001 Dec; 19(4):273-5. PubMed ID: 11746208
[TBL] [Abstract][Full Text] [Related]
36. Does CYP2E1 RsaI/PstI polymorphism confer head and neck carcinoma susceptibility?: A meta-analysis based on 43 studies.
Zhuo X; Song J; Liao J; Zhou W; Ye H; Li Q; Xiang Z; Zhang X
Medicine (Baltimore); 2016 Oct; 95(43):e5156. PubMed ID: 27787372
[TBL] [Abstract][Full Text] [Related]
37. Interaction of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferase M1 to breast cancer in Taiwanese woman without smoking and drinking habits.
Wu SH; Tsai SM; Hou MF; Lin HS; Hou LA; Ma H; Lin JT; Yeh FL; Tsai LY
Breast Cancer Res Treat; 2006 Nov; 100(1):93-8. PubMed ID: 16758119
[TBL] [Abstract][Full Text] [Related]
38. A polymorphism in the 5'-flanking region of the CYP2E1 gene and elevated lung adenocarcinoma risk in a Japanese population.
Iizasa T; Baba M; Saitoh Y; Suzuki M; Haga Y; Iyoda A; Chang H; Hiroshima K; Itoga S; Tomonaga T; Nomura F; Fujisawa T
Oncol Rep; 2005 Oct; 14(4):919-23. PubMed ID: 16142352
[TBL] [Abstract][Full Text] [Related]
39. Impact of CYP2E1 genotype in renal cell and urothelial cancer patients.
Farker K; Lehmann MH; Oelschlägel B; Haerting J; Hoffmann A; Janitzky V; Schubert J
Exp Toxicol Pathol; 1998 Sep; 50(4-6):425-31. PubMed ID: 9784018
[TBL] [Abstract][Full Text] [Related]
40. Associations of CYP2E1 rs2031920 and rs3813867 polymorphisms with colorectal cancer risk: a systemic review and meta-analysis.
Peng H; Xie SK; Huang MJ; Ren DL
Tumour Biol; 2013 Aug; 34(4):2389-95. PubMed ID: 23595220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
